Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | UPBD | PD |
|---|---|---|
| Price | $15.62 | $15.37 |
| Change today | ▲ 1.69% | ▼ 0.45% |
| Market cap | $910.64M | $1.21B |
| Return, 3 months | -21.2% | +46.9% |
| Return, year to date | -4.8% | +17.2% |
| Return, 1 year | -20.4% | -5.9% |
| P/E (TTM) | 10.1 | 7.6 |
| P/B | 1.2 | 5.2 |
| P/E percentile vs own 5y | 19th | 98th |
| Dividend yield | 9.99% | – |
| Revenue growth (YoY, latest qtr) | +0.5% | +0.8% |
| Net profit growth (YoY) | +39.4% | -18.1% |
| Gross margin | 49.1% | 84.8% |
| Operating margin | 5.1% | 6.5% |
| Net margin | 1.9% | 37.5% |
| Return on equity | 12.7% | 89.9% |
| Analyst target vs. price | +79.3% | -17.0% |
| Analyst buy share | 67% | 38% |
| RSI (14) | 35 | 64 |
| 30-day volatility | 28.0% | 43.9% |
| Max drawdown, 1 year | -33.0% | -65.5% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
